Septic Shock in the Course of Disseminated Tuberculosis in A COVID-19 Positive Patient with Concomitant AIDS

##plugins.themes.bootstrap3.article.main##

A 23-year-old male patient presented to the Provincial Hospital for Infectious Diseases in Warsaw, Poland in February 2022 with severe septic shock in the course of COVID-19 infection. The patient’s history and physical exam indicated a suspicion of HIV, TB, and COVID-19 triple coinfection. Numerous ulcers and phlegmon were present on the lower limbs and back with the patient complaining of difficulty walking. Laboratory tests came back positive for COVID-19, saliva tests were positive for active tuberculosis, and blood test results for the CD4 count were < 200 cells/cubic millimeter confirming an AIDS diagnosis.

Further testing and imaging revealed disseminated tuberculosis with involvement of bone in the left foot and thoracic spine, confirming Pott’s Disease. Treatment was started immediately for the septic shock with norepinephrine, vancomycin, meropenem, levofloxacin, and aggressive fluid resuscitation. COVID-19 treatment included oxygen mask therapy, systemic steroids and molnupiravir. Tuberculosis treatment was begun with isoniazid, rifampin, ethambutol, and pyrazinamide. Antiretroviral therapy (ART) was begun upon confirmed HIV/AIDS diagnosis using emtricitabine, tenofovir and dolutegravir. The patient was not previously on any ART and was not aware of his HIV/AIDS positive status.

  1. Bhalla K, Dalal P, Mehra S, Gupta A, Bhanot B. Tuberculosis presenting as septic shock in immunocompetent child: An unusual presentation. J Family Med Prim Care. 2020; 9(11): 5766-5768.
    DOI
     Google Scholar 
  2. Grigoriu BD, Jacobs FM, Mas AE, Prat D, Prévot S, Brivet FG. Tuberculose disséminée avec défaillance multiviscérale foudroyante au cours d'un sida [Disseminated tuberculosis with severe multi- organ failure in a patient with AIDS]. Rev Mal Respir. 2008; 25(7): 853-856. French.
    DOI
      DOI '>Google Scholar 
  3. Khan FY. Review of literature on disseminated tuberculosis with emphasis on the focused diagnostic workup. J Family Community Med. 2019; 26(2): 83-91.
     Google Scholar 
  4. Nancoz O, Kherad O, Perrin E, Hsu C, Lobrinus JA, Nendaz M. Disseminated tuberculosis presenting with polymorphonuclear effusion and septic shock in an HIV-seropositive patient: a case report. J Med Case Rep. 2010; 4: 155.
    DOI
     Google Scholar 
  5. Pravda J. Metabolic theory of septic shock. World J Crit Care Med. 2014; 3(2): 45-54.
    DOI
     Google Scholar 
  6. Riou C, du Bruyn E, Stek C, Daroowala R, Goliath RT, Abrahams F, et al. Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection. J Clin Invest. 2021; 131(12): e149125.
    DOI
     Google Scholar 
  7. Silva ED, Andrade LD, Araújo PS, Silveira VM, Padilha CE, Silva MA, et al. Case study of a patient with HIV-AIDS and visceral leishmaniasis co-infection in multiple episodes. Rev Inst Med Trop Sao Paulo. 2013; 55(6): 425-428.
    DOI
     Google Scholar 
  8. Vadillo M, Corbella X, Carratala J. AIDS presenting as septic shock caused by Mycobacterium tuberculosis. Scand J Infect Dis. 1994; 26(1): 105-106.
    DOI
     Google Scholar 

How to Cite

Ovcharuk, D., Jaszewski, I., & Porowski, D. (2023). Septic Shock in the Course of Disseminated Tuberculosis in A COVID-19 Positive Patient with Concomitant AIDS. European Journal of Medical and Health Sciences, 5(2), 1–4. https://doi.org/10.24018/ejmed.2023.5.2.1562

Search Panel